Abstract
Stenotrophomonas maltophilia is a global emerging pathogenic bacillus that is highly drug resistant and known to cause nosocomial infections in immunocompromised hosts. Because of their novel modes of action, bacteriocins are being proposed as alternatives to antibiotics for the treatment of infections caused by multidrug resistant bacteria. This study is the first report of modular bacteriocins called stenocins, which were discovered in the genomes of S. maltophilia. These two novel peptidoglycan-degrading bacteriocins were identified, cloned, and expressed in plants. We demonstrate that plant-expressed stenocins are functional and inhibit the growth of Stenotrophomonas strains in vitro.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
